Coal could be a source of cheap, nontoxic fluorescent nanoparticles useful for biomedicine.
Are we prepared to know the genetic flaws of the unborn?
Harvard Bioscience spin-off is stepping up its production of synthetic tracheas to supply clinical trials.
Using chemical reactions to synthesize complex protein drugs could help researchers create more effective medicines.
New cardiac devices are small enough to be delivered through blood vessels into the heart.
IBM researchers have developed a new polymer-like material to treat fungal infections.
A new brain-imaging technology may reveal the true risk of repetitive head injury in contact sports.
A Boston startup wants to create precise genome-editing treatments that can address more types of disease than previous gene therapy methods.
Delivering healthy bacteria in a pill could help patients harboring out-of-balance microbial communities.
A Kansas City hospital is pioneering genomic testing to solve life-threatening mysteries involving infants and kids with developmental disorders.